Table 3.
Hospital and long-term treatment of DVT and follow-up.
| Hospital management n, (%)∗ | ||
| Unfractionated heparin | 54 | (35.2%) |
| LMWH | 34 | (22.1%) |
| Prosthetic bypass | 18 | (11.7%) |
| PCDT | 13 | (8.4%) |
| Surgical thrombectomy | 3 | (1.9%) |
| IVC-filter | 1 | (0.6%) |
| Nonspecified anticoagulation | 31 | (20.1%) |
|
| ||
| Long-term treatment n, (%) | ||
| Prolonged/lifelong VKA | 135 | (71.8%) |
| Prolonged/lifelong VKA + | 32 | (17%) |
| Compression stockings | ||
| 6-month VKA | 11 | (5.8%) |
| 12-month VKA | 8 | (4.4%) |
|
| ||
| Follow-up duration in months ∗∗ | ||
| Mean ± SD | 12.85 ± 12.4 | |
| Range | 1–60 | |
DVT, deep vein thrombosis; IV, intravenous; LMWH, low molecular weight heparin; PCDT, pharmacomechanical catheter-directed thrombolysis; VKA, vitamin K antagonist; SD, standard deviation.
∗Out of 154, 34 cases are not reported.
∗∗Reported only in 60 cases.